Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 31

Cited In for PubMed (Select 18003852)


A dual vaccine against influenza & Alzheimer's disease failed to enhance anti-β-amyloid antibody responses in mice with pre-existing virus specific memory.

Davtyan H, Ghochikyan A, Hovakimyan A, Davtyan A, Cadagan R, Marleau AM, Albrecht RA, García-Sastre A, Agadjanyan MG.

J Neuroimmunol. 2014 Dec 15;277(1-2):77-84. doi: 10.1016/j.jneuroim.2014.10.002. Epub 2014 Oct 16.


Epitope analysis following active immunization with tau proteins reveals immunogens implicated in tau pathogenesis.

Selenica ML, Davtyan H, Housley SB, Blair LJ, Gillies A, Nordhues BA, Zhang B, Liu J, Gestwicki JE, Lee DC, Gordon MN, Morgan D, Dickey CA.

J Neuroinflammation. 2014 Sep 3;11:152. doi: 10.1186/s12974-014-0152-0.


Alzheimer's disease: is a vaccine possible?

Alves RP, Yang MJ, Batista MT, Ferreira LC.

Braz J Med Biol Res. 2014 Jun;47(6):438-44. Epub 2014 Jun 3.


The MultiTEP platform-based Alzheimer's disease epitope vaccine activates a broad repertoire of T helper cells in nonhuman primates.

Davtyan H, Ghochikyan A, Petrushina I, Hovakimyan A, Davtyan A, Cribbs DH, Agadjanyan MG.

Alzheimers Dement. 2014 May;10(3):271-83. doi: 10.1016/j.jalz.2013.12.003. Epub 2014 Feb 20.


Immunostimulant patches containing Escherichia coli LT enhance immune responses to DNA- and recombinant protein-based Alzheimer's disease vaccines.

Davtyan H, Ghochikyan A, Hovakimyan A, Petrushina I, Yu J, Flyer D, Madsen PJ, Pedersen LO, Cribbs DH, Agadjanyan MG.

J Neuroimmunol. 2014 Mar 15;268(1-2):50-7. doi: 10.1016/j.jneuroim.2014.01.002. Epub 2014 Jan 15.


Immunogenicity of epitope vaccines targeting different B cell antigenic determinants of human α-synuclein: feasibility study.

Ghochikyan A, Petrushina I, Davtyan H, Hovakimyan A, Saing T, Davtyan A, Cribbs DH, Agadjanyan MG.

Neurosci Lett. 2014 Feb 7;560:86-91. doi: 10.1016/j.neulet.2013.12.028. Epub 2013 Dec 19.


Immune complex formation impairs the elimination of solutes from the brain: implications for immunotherapy in Alzheimer's disease.

Carare RO, Teeling JL, Hawkes CA, Püntener U, Weller RO, Nicoll JA, Perry VH.

Acta Neuropathol Commun. 2013 Aug 9;1(1):48. doi: 10.1186/2051-5960-1-48.


Epitope-based DNA vaccine for Alzheimer's disease: translational study in macaques.

Evans CF, Davtyan H, Petrushina I, Hovakimyan A, Davtyan A, Hannaman D, Cribbs DH, Agadjanyan MG, Ghochikyan A.

Alzheimers Dement. 2014 May;10(3):284-95. doi: 10.1016/j.jalz.2013.04.505. Epub 2013 Jul 31.


Immunogenicity, efficacy, safety, and mechanism of action of epitope vaccine (Lu AF20513) for Alzheimer's disease: prelude to a clinical trial.

Davtyan H, Ghochikyan A, Petrushina I, Hovakimyan A, Davtyan A, Poghosyan A, Marleau AM, Movsesyan N, Kiyatkin A, Rasool S, Larsen AK, Madsen PJ, Wegener KM, Ditlevsen DK, Cribbs DH, Pedersen LO, Agadjanyan MG.

J Neurosci. 2013 Mar 13;33(11):4923-34. doi: 10.1523/JNEUROSCI.4672-12.2013.


Perspectives in molecular imaging using staging biomarkers and immunotherapies in Alzheimer's disease.

Leclerc B, Abulrob A.

ScientificWorldJournal. 2013;2013:589308. doi: 10.1155/2013/589308. Epub 2013 Feb 5. Review.


Refinement of a DNA based Alzheimer's disease epitope vaccine in rabbits.

Ghochikyan A, Davtyan H, Petrushina I, Hovakimyan A, Movsesyan N, Davtyan A, Kiyatkin A, Cribbs DH, Agadjanyan MG.

Hum Vaccin Immunother. 2013 May;9(5):1002-10. doi: 10.4161/hv.23875. Epub 2013 Feb 11.


Yeast expressed foldable quadrivalent Aβ15 elicited strong immune response against Aβ without Aβ-specific T cell response in wild C57BL/6 mice.

Tan L, Wang H, Tan X, Zou J, Yao Z.

Hum Vaccin Immunother. 2012 Aug;8(8):1090-8. doi: 10.4161/hv.20472. Epub 2012 Aug 1.


Combined treatment of Aβ immunization with statin in a mouse model of Alzheimer's disease.

Kou J, Song M, Pattanayak A, Lim JE, Yang J, Cao D, Li L, Fukuchi K.

J Neuroimmunol. 2012 Mar;244(1-2):70-83. doi: 10.1016/j.jneuroim.2012.01.008. Epub 2012 Feb 11.


Delivery of a DNA vaccine for Alzheimer's disease by electroporation versus gene gun generates potent and similar immune responses.

Davtyan H, Ghochikyan A, Movsesyan N, Ellefsen B, Petrushina I, Cribbs DH, Hannaman D, Evans CF, Agadjanyan MG.

Neurodegener Dis. 2012;10(1-4):261-4. doi: 10.1159/000333359. Epub 2012 Feb 1.


Frontal cortex neuropathology in dementia pugilistica.

Saing T, Dick M, Nelson PT, Kim RC, Cribbs DH, Head E.

J Neurotrauma. 2012 Apr 10;29(6):1054-70. doi: 10.1089/neu.2011.1957. Epub 2012 Apr 10.


The immunological potency and therapeutic potential of a prototype dual vaccine against influenza and Alzheimer's disease.

Davtyan H, Ghochikyan A, Cadagan R, Zamarin D, Petrushina I, Movsesyan N, Martinez-Sobrido L, Albrecht RA, García-Sastre A, Agadjanyan MG.

J Transl Med. 2011 Aug 1;9:127. doi: 10.1186/1479-5876-9-127.


How to get from here to there: macrophage recruitment in Alzheimer's disease.

Rezai-Zadeh K, Gate D, Gowing G, Town T.

Curr Alzheimer Res. 2011 Mar;8(2):156-63. Review.


Analysis of three plasmid systems for use in DNA A beta 42 immunization as therapy for Alzheimer's disease.

Qu BX, Lambracht-Washington D, Fu M, Eagar TN, Stüve O, Rosenberg RN.

Vaccine. 2010 Jul 19;28(32):5280-7. doi: 10.1016/j.vaccine.2010.05.054. Epub 2010 Jun 4.


Low concentrations of anti-Aβ antibodies generated in Tg2576 mice by DNA epitope vaccine fused with 3C3d molecular adjuvant do not affect AD pathology.

Movsesyan N, Davtyan H, Mkrtichyan M, Petrushina I, Tiraturyan T, Ross T, Agadjanyan MG, Ghochikyan A, Cribbs DH.

Hum Gene Ther. 2010 Nov;21(11):1569-76. doi: 10.1089/hum.2009.219.


Linear and conformation specific antibodies in aged beagles after prolonged vaccination with aggregated Abeta.

Vasilevko V, Pop V, Kim HJ, Saing T, Glabe CC, Milton S, Barrett EG, Cotman CW, Cribbs DH, Head E.

Neurobiol Dis. 2010 Sep;39(3):301-10. doi: 10.1016/j.nbd.2010.04.014. Epub 2010 May 6.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk